Budesonide Inhaler
developed to target bronchial inflammation to manage airway hyperactivity in respiratory conditions.
Strengths: 100 · 200mcg
Where to Check Availability
Medicine details
- Alternative names
Pulmicort
- Therapeutic class
Inhaled Corticosteroid
- Pharmacological class
Corticosteroid
- Contraindications
hypersensitivity to budesonide; acute asthma attack
- Minor side effects
hoarseness; throat irritation; cough
- Moderate side effects
oral candidiasis; nasopharyngitis
- Dosage forms
Inhalation powder
- Administration route
Inhalation use
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
24–48 hours
- Duration
daily maintenance
- Storage instructions
Store in dry place below 30°C.
- Drug interactions
strong CYP3A4 inhibitors
- Age restrictions
Use with caution in children.
Precautions and warnings
rinse mouth after use to prevent oral candidiasis; regular monitoring of height in children; check proper inhaler technique
Serious side effects
bronchospasm — requires immediate medical attention; adrenal suppression — requires immediate medical attention
Patient summary
developed to target bronchial inflammation to manage airway hyperactivity in respiratory conditions.
Mechanism of action
Budesonide is an anti-inflammatory corticosteroid. It suppresses the immune response in the airways, reducing oedema and mucus production, which facilitates easier breathing and decreases the frequency of exacerbations.
Pregnancy and breastfeeding
Pregnancy: Generally safe; benefits outweigh risks. Breastfeeding: Budesonide is excreted in milk, but effects on the infant are negligible at therapeutic doses.
Budesonide Inhaler
developed to target bronchial inflammation to manage airway hyperactivity in respiratory conditions.
Editorial Notes
- Active ingredient(s): Budesonide
- Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease
Usually available as
- 2 inhalers - 100 mcg1203-100-mcg-14262
- 2 inhalers - 200 mcg1203-200-mcg-14267